Metrogel 1%
Long considered to be the main standard topical treatment for rosacea, Metrogel 1% is the Galderma branded treatment that contains 1% of Metronidazole. Over the years Galderma has brought us Metrogel 0.75%, Metrolotion, Metrocream and now Metrogel 1% Pump 55gm.
Be sure to check out the Metrogel 1% User Reviews and How does Metrogel work?.
Recent Rosacea Blog Posts

Does the trip to the doctor, taking the paperwork to the chemist and then negotiating the insurance minefield get you down? Well you are not alone – many rosacea sufferers despair at how much it takes to get hold of your favourite prescription treatment. Well what would it take for the rosacea treatment main stays […]

This paper from Drugs R&D, details an extensive treatment regimen undertaken to deal with a patient with a severe case of rosacea. Click the photo above for a larger view of their symptoms and how they improved over time. Note that only one side of their face was treated with Mirvaso in the hours before […]

A little known program from Galderma may offer access to expensive rosacea treatments for many currently unaware rosacea sufferers. Galderma CareConnect offers rebates, for insured and fully uninsured rosacea sufferers for prescription treatments well known to rosacea sufferers; – Oracea, Mirvaso, Soolantra and Metrogel. The program is being promoted as being offered by `any US […]

A study has been released that headlines a result that even though Soolantra costs more than Finacea, overall it is actually cheaper than Finacea. The study uses a complicated formula to deduce that even though Soolantra sells for more per tube than Finacea, the overall cost versus the benefit you receive shows that Soolantra is […]

This just-published study finds that once your rosacea is under control, Soolantra once a day will likely do a better job at keeping papules and pustules at bay compared to Metrogel 0.75% twice per day. Why not Metrogel 1%? Interestingly this study did not compare Soolantra against Metrogel 1%, but Metrogel 0.75%. The leaves us […]